mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |